$MAPS

WM Technology, Inc. Reports Second Quarter 2026 Financial Results

WM TECHNOLOGY, INC. (MAPS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WM Technology, Inc. Reports Second Quarter 2026 Financial Results Q2 Revenue of $42.4 million and Net Income of $2.9 million Sustains Consecutive Quarters of Adjusted EBITDA Profitability Irvine, Calif.--(BUSINESS WIRE)--August 6, 2026-- WM Technology, Inc. (“WM Tech

Original reporting
Published Aug 6, 2026, 8:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MAPS
Neutral
medium confidence
Mentioned
$MAPS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MAPSNeutralMed
01

Why it matters

Key decision inputs are the reported Q2 revenue/client metrics, the sharp decline in Adjusted EBITDA versus the prior year, and the company’s expectation for mid-single-digit sequential revenue decline in Q3.

02

Market read

Traders can update near-term expectations using the disclosed Q2 financials and the explicit Q3 revenue decline assumption.

03

What to watch

The guidance assumes no acquisitions, restructurings, or legal settlements; traders may discount the outlook if they expect those events or if churn dynamics reverse in developing markets.

Relevance 7/10Novelty 8/10Timing: post-close filing, guidance for Q3 2026 disclosed today

Background

This is an SEC 8-K with Exhibit 99.1 reporting WM Technology’s Q2 2026 financial results and providing Q3 2026 revenue direction.

Company-level read

Ticker impact

$MAPSNeutralMedium confidence
Context

WM Technology reports Q2 2026 results with revenue $42.4M, net income $2.9M, and Adjusted EBITDA down to $5.0M, plus Q3 revenue decline guidance.

Expected impact

Likely choppy-to-negative near term if traders focus on the large Adjusted EBITDA drop and guided mid-single-digit sequential revenue decline.

Evidence & confidence

The article includes current-quarter financials and explicit Q3 revenue direction, but it is OTC-listed and the magnitude of the move is not provided in the text.

Market effects

Cannabis-adjacent marketplace operators face customer margin compression and spend declines, reinforcing a cautious read-through for ad and software spend in the sector.

No specific regional demand signal beyond U.S. state-legal markets.

Limited, as the business is described as U.S. state-legal focused.

Counterpoint

GAAP net income increased to $2.9M and cash rose to $60.5M, which could offset concerns about Adjusted EBITDA weakness for balance-sheet-focused traders.

Key entities

  • WM Technology, Inc.

    OTC-listed marketplace and technology solutions provider operating Weedmaps; subject of the 8-K earnings release.

  • Doug Francis

    CEO and Chairman quoted on marketplace strengthening and expansion into underpenetrated states.

  • Susan Echard

    CFO quoted on liquidity, expense discipline, and targeted marketing and automation initiatives.

Related articles

$GSHighAI 9/10

The Goldman Sachs Group Inc (GS) (Q3 2026) Earnings Call Highlights: Record Advisory

Goldman Sachs (GS) reported Q3 2026 net revenues of $18.7B, with record advisory revenues and 72% YoY growth in equities. Asset management revenues rose 14% YoY. Challenges include geopolitical tensions, inflation, and credit quality concerns. CEO David Solomon addressed succession plans, market structure, and AI financing risks. The company maintains a strong capital buffer and expects active Q4 trading. GS's durable revenues now represent 45% of YTD revenues.

$JNJHighAI 9/10

Johnson & Johnson (JNJ) (Q3 2026) Earnings Call Highlights: Talc Settlement Weighs

Johnson & Johnson (JNJ) reported Q3 2026 operational sales growth of 6%, exceeding expectations. Innovative Medicine grew 7.9%, with key products like TREMFYA and CARVYKTI showing strong sales. The company raised its full-year guidance. However, MedTech grew only 2.5%, and talc litigation expenses impacted GAAP earnings. JNJ expects future growth from pipeline advancements and strategic investments.

$CMedAI 8/10

Citigroup Inc (C) (Q3 2026) Earnings Call Highlights: Best Q3 Revenue in a Decade as Net

Citigroup reported its best Q3 revenue in a decade, but faced challenges like flat consumer cards revenue and expected market revenue declines. Expenses rose 3%, and cost of credit was $2.6 billion. CEO Jane Fraser and CFO Gonzalo Luchetti reaffirmed confidence in exceeding the full-year ROTCE target of above 11% and reiterated near-term targets of 11% to 13% for 2027-2028. The firm is investing in technology and marketing, with $3 billion in buybacks in Q3.

$DPZMed

Domino's Pizza Inc (DPZ) Q3 2026 Earnings Call Highlights: Solid Order Growth and Global

Domino's Pizza Inc (DPZ) reported Q3 2026 earnings, lowering guidance for US and international same-store sales growth, net new store openings, and global retail sales growth due to macroeconomic pressures and franchisee profitability challenges. CEO Joe Jordan discussed strategies to balance promotions, improve ticket growth, and manage delivery channels. The company expects continued pressure on franchisee profits and store development until conditions improve.